Serum or plasma biomarkers of inflammation, especially IL-6 and C-reactive protein (CRP), were prospectively associated with cognitive decline in multiethnic cohorts of older populations before the clinical onset of dementia, AD, and vascular dementia [16–20]. This evidence concerns the gene IL6 and Alzheimer disease.